BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18471003)

  • 1. Heterogeneous domains and membrane permeability in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch.
    Karve S; Bajagur Kempegowda G; Sofou S
    Langmuir; 2008 Jun; 24(11):5679-88. PubMed ID: 18471003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane heterogeneities and fusogenicity in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch.
    Bhagat M; Sofou S
    Langmuir; 2010 Feb; 26(3):1666-73. PubMed ID: 19813725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
    Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S
    Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Floret-shaped solid domains on giant fluid lipid vesicles induced by pH.
    Bandekar A; Sofou S
    Langmuir; 2012 Mar; 28(9):4113-22. PubMed ID: 22276950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo.
    Bandekar A; Zhu C; Gomez A; Menzenski MZ; Sempkowski M; Sofou S
    Mol Pharm; 2013 Jan; 10(1):152-60. PubMed ID: 23134440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propyl paraben on the dipalmitoyl phosphatidic acid vesicles.
    Panicker L
    J Colloid Interface Sci; 2007 Jul; 311(2):407-16. PubMed ID: 17451735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin.
    Bandekar A; Karve S; Chang MY; Mu Q; Rotolo J; Sofou S
    Biomaterials; 2012 Jun; 33(17):4345-52. PubMed ID: 22429980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-l-lysines and poly-l-arginines induce leakage of negatively charged phospholipid vesicles and translocate through the lipid bilayer upon electrostatic binding to the membrane.
    Reuter M; Schwieger C; Meister A; Karlsson G; Blume A
    Biophys Chem; 2009 Sep; 144(1-2):27-37. PubMed ID: 19560854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of lysozyme charge influences interaction with phospholipid vesicles.
    Zschörnig O; Paasche G; Thieme C; Korb N; Arnold K
    Colloids Surf B Biointerfaces; 2005 Apr; 42(1):69-78. PubMed ID: 15784328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low permeability of liposomal membranes composed of bipolar tetraether lipids from thermoacidophilic archaebacterium Sulfolobus acidocaldarius.
    Komatsu H; Chong PL
    Biochemistry; 1998 Jan; 37(1):107-15. PubMed ID: 9425030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity.
    Karve S; Bandekar A; Ali MR; Sofou S
    Biomaterials; 2010 May; 31(15):4409-16. PubMed ID: 20189243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of various membrane physical-chemical properties on the aggregation kinetics of insulin.
    Grudzielanek S; Smirnovas V; Winter R
    Chem Phys Lipids; 2007; 149(1-2):28-39. PubMed ID: 17603032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hydrophobicity scale for the lipid bilayer barrier domain from peptide permeabilities: nonadditivities in residue contributions.
    Mayer PT; Xiang TX; Niemi R; Anderson BD
    Biochemistry; 2003 Feb; 42(6):1624-36. PubMed ID: 12578376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phosphatidylcholine/polyethylene glycol-lipid aggregates and their use as coatings and carriers in capillary electrophoresis.
    Lindén MV; Meinander K; Helle A; Yohannes G; Riekkola ML; Butcher SJ; Viitala T; Wiedmer SK
    Electrophoresis; 2008 Feb; 29(4):852-62. PubMed ID: 18213602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fluoxetine with phosphatidylcholine liposomes.
    Momo F; Fabris S; Stevanato R
    Biophys Chem; 2005 Oct; 118(1):15-21. PubMed ID: 15994001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of apomyoglobin with membranes: mechanisms and effects on heme uptake.
    Vernier G; Chenal A; Vitrac H; Barumandzadhe R; Montagner C; Forge V
    Protein Sci; 2007 Mar; 16(3):391-400. PubMed ID: 17242377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic delivery of macromolecules 4. Head group-dependent membrane permeabilization by pH-sensitive detergents.
    Asokan A; Cho MJ
    J Control Release; 2005 Aug; 106(1-2):146-53. PubMed ID: 15979190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid composition alters drug action at the nicotinic acetylcholine receptor.
    Baenziger JE; Ryan SE; Goodreid MM; Vuong NQ; Sturgeon RM; daCosta CJ
    Mol Pharmacol; 2008 Mar; 73(3):880-90. PubMed ID: 18055762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-4,5-bisphosphate ionization and domain formation in the presence of lipids with hydrogen bond donor capabilities.
    Graber ZT; Jiang Z; Gericke A; Kooijman EE
    Chem Phys Lipids; 2012 Sep; 165(6):696-704. PubMed ID: 22820347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.